The medical regulatory agency has also concluded that reviews suggest a CAUSAL ROLE for Strattera in inducing homicidal behaviours, aggression and hostility.
It took over two years of foot dragging before the medical authorities in Europe finally decided that Eli Lilly should issue warnings about psychotic reactions in the label for Strattera. But now it’s finally done.
If Lilly doesn’t cause more delays, the new warning text reflecting “the risk of the onset or exacerbation of serious psychiatric disorders, including psychotic reactions, hallucinations, mania and agitation” (MHRA March 30, 2008), should be issued in a few weeks.
Aggression and hostility are already listed harmful effects of Strattera.
What is new is a review of 34 cases of homicidal behaviour and 2 cases of homicide in connection with the drug. In the review it is revealed that in 17 of the 34 cases the homicidal behaviour disappeared when Strattera was discontinued. In one case the drug was re-administrated and the thoughts of murdering came back.
The regulatory agency concluded: “The reviews of homicidal behaviours as well of aggression and hostility suggest that a causal relationship between atomoxetine [Strattera] and physical, verbal and written aggressive behaviours, sometimes of a severe nature, is possible.” (MHRA March 30, 2008)
This conclusion has not yet led to any action from the agency – but parents and doctors should absolutely know that this causal relationship has been shown.
Janne Larsson
Reporter – investigating psychiatry
We have read in the media that “psychiatric disorders” and the number of suicides are increasing among young women. This increase is in Sweden parallel with a heavy increase in the prescription of antidepressants and other psychiatric drugs to yo ...
Released On: 12/9/2014
Views: 5155
The study was hailed in media and used for new prescription guidelines. But the actual disastrous results were concealed. No one – except the researchers involved – knew that 26% of the subjects receiving the “ADHD drug”
Released On: 11/11/2014
Views: 8503
The European medical agencies have disapproved the ADHD drug Concerta for adults. The well selected short-term clinical trials did not hold: No certain positive effects; clear evidence that Concerta can cause anxiety and agitated conditions in ad ...
Released On: 10/7/2011
Views: 15556
Released On: 11/7/2010
Views: 7661
Released On: 3/30/2010
Views: 4141
Released On: 3/5/2010
Views: 11698
Released On: 12/2/2008
Views: 17617
Released On: 8/8/2008
Views: 4178
Released On: 6/26/2008
Views: 5439
Released On: 4/28/2008
Views: 3394
Newly uncovered data show that psychiatric drugs were behind 75 percent of ALL suicides among women (18-84) in Sweden (2006); antidepressants were behind 52 percent.
Released On: 2/7/2008
Views: 4500
Released On: 1/22/2008
Views: 15825
Released On: 10/7/2007
Views: 10783
Released On: 9/13/2007
Views: 5236